Journal of Cancer Biomoleculars and Therapeutics Officially Indexed in DOAJ

We are pleased to announce that the Journal of Cancer Biomoleculars and Therapeutics (JCBT, EISSN: 3060-8856) has been formally accepted for inclusion in the Directory of Open Access Journals (DOAJ).

DOAJ is a globally recognized, authoritative open-access journal database that strictly evaluates journals against standardized peer review frameworks, transparent open-access publishing policies, and full compliance with academic ethics requirements.

For general information about DOAJ, please visit: https://doaj.org
To view JCBT’s official DOAJ journal record, please visit: https://doaj.org/toc/3060-8856

What this means for our journal and academic community
Increased visibility and discoverability
DOAJ is the world’s premier index for peer-reviewed open-access journals, widely consulted by researchers, academic libraries and research funding bodies worldwide.
Enhanced academic credibility
Inclusion in DOAJ officially confirms that JCBT adheres to strict international publishing standards, including transparent editorial policies, rigorous peer review, and globally recognized open-access best practices.
Broader dissemination of your research
All articles published in JCBT will become more accessible and retrievable across global academic networks, boosting citation opportunities and the overall impact of authors’ scholarly work.

We extend our sincere gratitude to our authors, reviewers, editorial board members, and readers for their continued support and contributions. As a DOAJ‑indexed journal, we will maintain the highest standards of publication ethics and transparency. We will continue to optimize our metadata quality and publishing standards as we pursue inclusion in further major international academic databases. We welcome researchers worldwide to submit original research and review articles to JCBT.

Editorial Office
Journal of Cancer Biomoleculars and Therapeutics